NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Humana Inc. (“Humana” or the “Company”) (NYSE:HUM). The investigation concerns whether Humana and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On May 1, 2025, the U.S. Department of Justice filed a complaint against insurance broker organizations, including Humana, alleging t ...

Core Viewpoint - A class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. for misleading investors regarding the approval prospects of its Biologics License Application for lomab-B, leading to significant stock price decline [1][4]. Group 1: Lawsuit Details - The class action lawsuit is filed in the U.S. District Court for the Southern District of New York on behalf of investors who acquired Actinium securities from October 31, 2022, to August 2, 2024 [1]. - Investors have until May 27, 2025, to apply to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Regulatory Update - On August 5, 2024, Actinium announced that the FDA determined the data from its Sierra trial did not support a BLA filing for lomab-B, necessitating an additional clinical study [3]. - Following this announcement, Actinium's share price fell by $3.69, or approximately 59%, from $6.17 on August 2, 2024, to $2.48 on August 5, 2025 [3]. Group 3: Allegations - The complaint alleges that during the Class Period, Actinium misled the market into believing that the data submitted for its BLA would meet FDA guidelines for acceptance and approval [4].

NEW YORK , May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Arvinas, Inc. ("Arvinas" or the "Company") (NASDAQ:ARVN). The investigation concerns whether Arvinas and/or certain of its officers have violated the federal securities laws. [LEARN MORE ABOUT THE INVESTIGATION] On May 1, 2025, Arvinas and its partner Pfizer announced that they would discontinue development of vepdegestrant, an oral SERD for HR-positive breast cancer. The move eliminated ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fluence Energy, Inc. due to significant losses suffered by investors, particularly following a substantial decline in the company's stock value and allegations of misleading statements regarding its financial health and business relationships [2][4][5]. Group 1: Company Overview - Fluence Energy, Inc. is publicly traded on NASDAQ under the ticker FLNC [2]. - The company has faced a 49% year-over-year revenue decline as reported on February 11, 2025, leading to a stock price drop of over 45% [5]. Group 2: Legal Allegations - The complaint against Fluence alleges violations of federal securities laws, including making false or misleading statements and failing to disclose critical information about its relationships with major partners Siemens AG and The AES Corporation [4]. - Specific allegations include claims that Siemens Energy accused Fluence of engineering failures and fraud, and that Fluence's financial results were inflated as these partners were moving to divest [4]. Group 3: Investor Impact - Investors who suffered losses exceeding $75,000 between October 28, 2021, and February 10, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1][2]. - The deadline for investors to seek the role of lead plaintiff in the federal securities class action is May 12, 2025 [2][6].

Core Viewpoint - A class action lawsuit has been filed against Napco Security Technologies, Inc. due to significant discrepancies between the company's projected growth and actual financial performance, particularly in its hardware division [1][2]. Financial Performance - On February 3, 2025, Napco reported a notable decline in hardware sales for the second quarter of fiscal 2025, attributing the drop primarily to reduced sales from two major distributors [3]. - Following the disappointing sales results, the company retracted its long-term EBITDA margin target of 45%, expressing uncertainty about achieving this goal by the end of fiscal 2026 [3]. - Napco's stock price experienced a sharp decline, falling from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decrease of approximately 26.62% in just one day [3]. Legal Proceedings - The class action lawsuit, Shailesh Patel v. Napco Security Technologies, Inc., was initiated in the United States District Court for the Eastern District of New York, targeting investors who acquired Napco securities between February 5, 2024, and February 3, 2025 [1][4]. - Investors have until June 24, 2025, to request appointment as lead plaintiff in the lawsuit, although participation in any recovery does not require serving as lead plaintiff [4].

Core Viewpoint - A class action lawsuit has been initiated against Skyworks Solutions, Inc. due to allegations of misleading investors regarding the company's expected revenue and business prospects during a specified period [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit spans from August 8, 2023, to February 5, 2025, during which investors are claimed to have been provided with material information about Skyworks' expected revenue for fiscal year 2025 [2]. - The lawsuit alleges that the defendants expressed confidence in Skyworks' ability to grow its mobile business and diversify its offerings through new technology investments [2]. Group 2: Financial Performance - On February 5, 2025, Skyworks reported its financial results for Q1 of fiscal year 2025 and issued lower-than-expected revenue guidance for Q2, attributing this to an intensified competitive landscape [3]. - Following the announcement, Skyworks' stock price plummeted from $87.08 per share to $65.60 per share on February 6, 2025, marking a decline of over 24% in just one day [3]. Group 3: Legal Process - Investors who suffered losses in Skyworks securities have until May 5, 2025, to request appointment as lead plaintiff in the lawsuit, although participation in any recovery does not require serving as lead plaintiff [4]. Group 4: Law Firm Background - Levi & Korsinsky, the law firm handling the case, has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bakkt Holdings, Inc. due to allegations of misleading statements regarding its revenue sources and client relationships, particularly following the termination of key contracts that significantly impact its financial outlook [2][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses in Bakkt to discuss their legal options, with a deadline of June 2, 2025, to seek the role of lead plaintiff in a federal securities class action [1][2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. Group 2: Allegations Against Bakkt - The complaint alleges that Bakkt misrepresented the stability and diversity of its crypto services revenue, which was heavily reliant on a single contract with Webull [4]. - Bakkt disclosed that Webull accounted for 74% of its crypto services revenue and that 98% of its total revenue was derived from crypto services during the nine months ending September 30, 2024 [5]. - Additionally, Bank of America, which contributed 17% of Bakkt's loyalty services revenue, is also terminating its contract, leading to a projected 73% loss in top-line revenue [5]. Group 3: Market Reaction - Following the announcement of the contract terminations, Bakkt's share price fell by $3.50, or 27.3%, closing at $9.33 per share on March 18, 2025, with unusually high trading volume [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against The Trade Desk, Inc. due to allegations of misleading statements and execution challenges related to the rollout of its new platform, Kokai, which negatively impacted the company's revenue growth [2][4]. Group 1: Allegations and Impact - The complaint alleges that Trade Desk and its executives violated federal securities laws by making false statements and failing to disclose significant execution challenges in transitioning clients to Kokai from the older platform, Solimar [4]. - The execution challenges delayed the Kokai rollout and negatively impacted Trade Desk's business operations and revenue growth [4]. - Following the release of disappointing fourth quarter 2024 revenue results, Trade Desk's stock price dropped over 32%, from $122.23 to $81.92 per share [5][6]. Group 2: Legal Proceedings - Investors who suffered losses exceeding $100,000 between May 9, 2024, and February 12, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [1]. - There is an April 21, 2025 deadline for investors to seek the role of lead plaintiff in the federal securities class action against Trade Desk [2]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will direct and oversee the litigation on behalf of the class [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by May 19, 2025 [2][4]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false or misleading statements and failed to disclose critical information, including shipping excess products, inflating revenue, and facing scrutiny from insurers like Tricare [4]. - A report published by medical journal STAT accused Zynex of an "oversupplying scheme," leading to insurers removing the company from their networks [5]. - Following the report, Zynex's stock price dropped by $0.50 per share, or 5%, closing at $9.35 on June 4, 2024, amid heavy trading volume [5]. Group 2: Financial Performance and Market Reaction - On March 11, 2025, Zynex reported a significant revenue shortfall for Q4 2024, attributing it to slower payments from certain payers and a temporary suspension of payments from Tricare [6]. - The announcement led to a drastic decline in Zynex's stock price, which fell by $3.59 per share, or 51.3%, closing at $3.41 on March 12, 2025, also on unusually heavy trading volume [7].

Core Viewpoint - A securities class action lawsuit has been filed against Monolithic Power Systems, Inc. for alleged misleading statements and undisclosed risks affecting its business performance and relationship with Nvidia [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Western District of Washington on behalf of investors who purchased Monolithic common stock between February 8, 2024, and November 8, 2024 [1]. - The lead plaintiff deadline for the lawsuit is April 7, 2025 [1][4]. Group 2: Allegations Against Monolithic - The complaint alleges that Monolithic's voltage regulator modules and power management integrated circuits faced significant performance and quality control issues [3]. - These defects reportedly negatively impacted the performance of products offered by Nvidia that utilized Monolithic's components [3]. - Monolithic is accused of failing to adequately address known issues affecting its power management solutions supplied to Nvidia, leading to irreparable damage to their relationship [3]. - As a result of these issues, Monolithic is said to be exposed to material undisclosed risks of significant business, financial, and reputational harm [3]. Group 3: Lead Plaintiff Process - Investors may seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or may choose to remain an absent class member [4]. - The lead plaintiff is typically the investor or small group of investors with the largest financial interest and who are representative of the proposed class [4].